Aisha Al-Breiki
Overview
Explore the profile of Aisha Al-Breiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandoval M, Wechsler A, Alhajji Z, Viets-Upchurch J, Brock P, Lipe D, et al.
Heliyon
. 2023 Feb;
9(3):e13725.
PMID: 36851967
Immune checkpoint inhibitor monoclonal antibodies allow the host's immune system to attack tumors, which has revolutionized cancer care over the last decade. As the use of immune checkpoint inhibitors has...
2.
Qdaisat A, Wechsler A, Cruz Carreras M, Menendez J, Lipe D, Highsmith E, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139673
Incidental venous thromboembolism (VTE) is common in cancer patients and identifying factors associated with these events can improve the management plan. We studied the characteristics of concomitant deep vein thrombosis...
3.
Lipe D, Qdaisat A, Rajha E, Al-Breiki A, Cruz Carreras M, Chaftari P, et al.
Res Pract Thromb Haemost
. 2022 Aug;
6(6):e12761.
PMID: 36000091
Background: Central venous catheters raise the risk of catheter-related thrombosis (CRT) in patients with cancer, typically affecting the upper extremity. Management of CRT involves catheter removal and anticoagulation. However, robust...
4.
Yeung S, Qdaisat A, Chaftari P, Lipe D, Merlin J, Rajha E, et al.
J Am Coll Emerg Physicians Open
. 2021 Jan;
1(6):1637-1659.
PMID: 33392573
Rapid advances in cancer immunotherapy using immune checkpoint inhibitors have led to significantly improved survival. Rapid identification of the toxicity syndromes associated with these therapeutic agents is very important for...
5.
Qdaisat A, Kamal M, Al-Breiki A, Goswami B, Wu C, Zhou S, et al.
Blood Adv
. 2020 Apr;
4(8):1606-1614.
PMID: 32311012
Incidental pulmonary embolisms (IPEs) are common in cancer patients. Examining the characteristics and outcomes of IPEs in cancer patients can help to ensure proper management, promoting better outcomes. To determine...